HOME >> BIOLOGY >> NEWS
Findings offer further understanding about growth and development in young male gymnasts

(September 10, 2003) - Bethesda, MD -- Intense training has been found to delay the onset of puberty in females by altering normal hormonal development. This has led to delayed pubertal onset, delayed age at first menarche and failure to develop mature skeletal structure. In males, despite evidence that physical activity can also result in hormonal changes, there have been few studies that examined the relationship between training and the onset of puberty.

Accordingly, a new study has been undertaken to evaluate the effect of intense training during somatic growth and skeletal development on the onset of puberty in male gymnasts. The researchers hypothesized that after several years of training, the increased energy expenditure by elite gymnasts would result in lower levels of testosterone than other boys of their age, leading to a delay in physical growth characteristics and markers of sexual maturation.

A New Study

The study, entitled "Physical and Pubertal Development in Young Male Gymnasts" was conducted by Brendon Gurd and Panagiota Klentrou, both of the Department of Physical Education and Kinesiology, Brock University, St. Catharines, Ontario, Canada. Their findings appear in the September 2003 edition of the Journal of Applied Physiology. The journal is one of 14 scientific journals published monthly by the American Physiological Society (APS) (http://www.the-aps.org).

Methodology

A total of 21 elite gymnasts (GYM) (13.3 0.3 years) were recruited from competitive gymnastics clubs around Southern Ontario, Canada. In order to qualify for the experimental group, gymnasts had to be competing at a minimum of a provincial level and training at least 15 hours per week. A total of 24 age-matched boys (13.5 0.3 years) were recruited from recreational martial arts classes to participate as the control groups (CON). These boys were training not more than two hours per weeks. '"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
23-Sep-2003


Page: 1 2 3

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings could aid efforts to harness nature for making drugs
5. Findings offer clue to how molecule can both stimulate, suppress cell growth
6. Findings in frog oocytes may help study of chromosome physiology
7. Findings aid understanding of neurodegenerative diseases
8. Findings show exceptional longevity runs in families
9. Findings give insight into how colon cells transform into precancerous polyps
10. Findings conclude sustained caffeine intake negates the benefits of creatine supplements
11. Findings link disease specific anitbodies to activation of T cells for the first time

Post Your Comments:
(Date:5/21/2013)... occur in the body, stem cells in the ... differentiating into mature immune cells that can fight ... deplete these cell populations, potentially leading to the ... Now, a team of researchers led by biologists ... found that, in mouse models, the molecule microRNA-146a ...
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... new University of Michigan Water Center today awarded ... Great Lakes restoration and protection efforts. , The ... diverse projects, including efforts to track the remediation ... techniques to control non-native weedy plant invasions; study ... fish responses to restoration activities. , The grants ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
(Date:5/21/2013)... Wisc. (PRWEB) May 21, 2013 ... parts distributor , will be exhibiting for the ... Advancement of Medical Instrumentation (AAMI) 2013 Conference and ... purchase, support, distribute, and manufacture healthcare technologies. This ... in Long Beach, California. , The three-day ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: